Drug General Information
Drug ID	D08VWL
Former ID	DIB010490
Drug Name	BRL-42715
Drug Type	Small molecular drug
Indication	Bacterial infections [ICD9: 001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104; ICD10:A00-B99]		Terminated	[544791]
Company	SmithKline Beecham plc
Structure		Download 2D MOL 3D MOL
Formula	C10H7N4NaO3S
Canonical SMILES	N12C(=O)/C(=C/c3nnn(c3)C)/[C@H]1SC=C2C(=O)[O-].[Na+]
CAS Number	CAS 102209-75-6
PubChem Compound ID	23665639
Target and Pathway
Target(s)	Beta-lactamase	Target Info	Inhibitor	[533347]
References
Ref 544791	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001128)
Ref 533347	In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor. Antimicrob Agents Chemother. 1989 Sep;33(9):1580-7.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.